There has been a reported breakthrough in the race to develop a Covid-19 vaccine by scientists at Oxford University. An immune response to the new vaccine called ChAdOx1 nCoV-19 has indicated a strong “double defence”, whereby both antibodies and “killer” T-cells were reported to have been present in blood samples from volunteers in the first human phase of testing. The information was provided to The Telegraph by a senior source. Further media coverage will be reported on these developments on Monday 20th July.
 logo final copy.png)
The Hippocratic Editorial and VT team. Please send your suggestions to [email protected]
Latest posts by Hippocratic Post (see all)
- World-first breakthrough for bowel cancer immunotherapy - 24th October 2025
- The future of sepsis research - 24th October 2025
- Unpaid carers working longer hours - 24th October 2025
